Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,744,825
-$202,240 QoQ
Shares Held
155,516
+10.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#720
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BRIGHTON JONES LLC holds $86,570,928 across 13 Drug Manufacturers - General names. PFE ranks #7 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
17,958 | $21,539,365 | |
| 2 | JNJ |
Johnson & Johnson
|
57,725 | $14,660,418 | |
| 3 | AMGN |
Amgen Inc
|
34,281 | $12,413,835 | |
| 4 | MRK |
Merck & Co., Inc.
|
90,183 | $11,588,515 | |
| 5 | ABBV |
AbbVie Inc.
|
33,304 | $8,380,618 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
122,001 | $7,029,697 | |
| 7 | PFE |
Pfizer Inc
This page
|
155,516 | $3,744,825 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
18,796 | $2,374,686 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,744,825 | 155,516 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,947,065 | 140,565 | Shares | Sole | 2026-08-07 | |
| 2025-12-31 | $10,843,626 | 435,487 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $14,218,426 | 558,023 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $13,156,914 | 542,777 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $16,767,959 | 661,719 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $17,677,416 | 666,318 | Shares | Sole | 2025-03-04 | |
| 2024-09-30 | $1,394,936 | 48,201 | Shares | Sole | 2025-03-04 | |
| 2024-06-30 | $30,822,376 | 1,101,586 | Shares | Sole | 2025-03-04 | |
| 2024-03-31 | $3,393,159 | 122,276 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,765,402 | 61,320 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $2,027,184 | 61,115 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $2,380,678 | 64,904 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $2,412,912 | 59,140 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $2,507,736 | 48,941 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $2,132,074 | 48,722 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,508,670 | 47,848 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $2,474,606 | 47,800 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,628,906 | 44,520 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $1,680,013 | 39,061 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $1,485,103 | 37,924 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,737,554 | 47,959 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,734,892 | 47,131 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,678,656 | 45,740 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,299,630 | 39,744 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,316,793 | 40,343 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||